anikatherapeutics.com (ANIK) Price to Earnings Ratio

Corporate emblem and logo of Anika Therapeutics, Inc. (ANIK)

Geopolitical instability and supply chain disruptions are limiting market access for Anika Therapeutics (ANIK). This chart on GURU.Markets with the -99.10 indicator confirms the impact of these factors. However, the business relies on its authority in joint regeneration and physician trust in its implants. Stable operating leverage during product line expansions allows for effective cost control while maintaining high margins.

Anika (ANIK) Price to Earnings Ratio: for the period 07/04/2022 - 11/17/2026

Comprehensive metric breakdowns and analytics for Anika Therapeutics, Inc. (ANIK)

General company analysis:Anika Therapeutics Inc. - ANIK
Original product of anikatherapeutics.com

The P/E ratio reflects the market value of a single unit of profit, determining the extent to which an asset is overvalued or undervalued. The coefficient is calculated as the ratio of market capitalization to net income, making it extremely sensitive to earnings volatility. By analyzing the price-to-earnings trend, an investor can identify the gap between accounting data and market expectations. For Anika Therapeutics (ANIK), this balance is complicated by strict health insurance limits that constrain the company's pricing power.

Analysis of competing companies

Price to Earnings Ratio BSX|Price to Earnings Ratio EW (Edwards Lifesciences Corporation)|Business Payback Period ResMed Inc.|P/E Multiple PODD (insulet.com)|ZBH (Zimmer Biomet Holdings, Inc.) - Market Cap to Net Income|CooperSurgical - P/E Multiple|Market Cap to Net Income ALGN|GMED: P/E Multiple|Market Cap to Earnings TransMedics Group (TMDX)|ATEC (Alphatec) - P/E Multiple|Price to Earnings Multiple AORT (Artivion)|Price to Earnings Ratio ENOV (Enovis)|IART (Integra LifeSciences Corp) - Company Value to Net Income|Price to Earnings Ratio Establishment Labs Inc ESTA|BBNX - Price to Earnings Ratio|IRADIMED Corp - P/E Multiple|Market Cap to Earnings Embecta Corp.|TNDM: P/E Multiple|Price to Earnings Multiple AXGN|SIBN (SI-BONE Medical) - P/E Multiple|Orthofix International (OFIX) - Business Payback Period|P/E Multiple BVS|Price to Earnings Ratio OrthoPediatrics KIDS|P/E Multiple TMCI (treace.com)|P/E Multiple Blade Air Mobility SRTA|CARL - Price to Earnings Ratio|RXST: Price to Earnings Ratio|CLPT (ClearPoint) - Price to Earnings Ratio|Stereotaxis, Inc. - Company Value to Net Income|STIM (Neuronetics, Inc) - P/E Multiple|Market Cap to Earnings Sight Sciences Inc. SGHT|Price to Earnings Ratio orchestrabiomed.com (OBIO)|InspireMD, Inc. (NSPR) - Market Cap to Net Income Ratio|Jin Medical International Ltd. - Price to Earnings Ratio|P/E Multiple Vivani VANI|Xtant Medical Holdings, Inc. - P/E Multiple|Business Payback Period NeuroOne NMTC|Modular Medical, Inc. (MODD) - Price to Earnings Ratio|Price to Earnings Ratio Myomo, Inc|Price to Earnings Ratio envoymedical.com|Price to Earnings Ratio Vivos Therapeutics (VVOS)|P/E Multiple NVNO|SINT - Market Cap to Earnings|Price to Earnings Ratio Tenon Medical, Inc. TNON|LFWD: Price to Earnings Multiple|AMIX: Price to Earnings Ratio|Business Payback Period invobioscience.com IVF|BBLG: P/E Multiple|Axonics Modulation Technologies (AXNX) - P/E Multiple|BIOL (Biolase Inc.) - P/E Multiple|Market Cap to Earnings dynatronics.com DYNT|P/E Multiple FNA|Price to Earnings Ratio INVO (INVO Bioscience Inc.)